Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Number of holders
-
310
-
Total 13F shares, excl. options
-
553,328,719
-
Shares change
-
-9,490,392
-
Total reported value, excl. options
-
$5,583,781,669
-
Value change
-
-$111,475,682
-
Put/Call ratio
-
21%
-
Number of buys
-
144
-
Number of sells
-
-163
-
Price
-
$10.09
Significant Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q1 2025
386 filings reported holding ROIV - Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share as of Q1 2025.
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) has 310 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 553,328,719 shares
of 695,088,397 outstanding shares and own 80% of the company stock.
Largest 10 shareholders include QVT Financial LP (65,793,779 shares), SB INVESTMENT ADVISERS (UK) LTD (61,852,718 shares), FMR LLC (51,666,511 shares), VIKING GLOBAL INVESTORS LP (46,013,752 shares), BlackRock, Inc. (41,659,488 shares), VANGUARD GROUP INC (40,767,590 shares), MORGAN STANLEY (35,926,758 shares), STATE STREET CORP (18,861,653 shares), Rubric Capital Management LP (17,767,076 shares), and Patient Square Capital LP (12,480,000 shares).
This table shows the top 310 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.